Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men

Journal of Women's Health

Volumn 13, Issue 10, 2004, Pages 1101-1107

  Bennett, Susan ^a   Sager, Philip ^b   Lipka, Leslie ^b   Melani, Lorenzo ^b   Suresh, Ramachandran ^b   Veltri, Enrico ^b  

^a Cardiology Associates PC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENZYME INHIBITION; FEMALE; HEPATITIS; HUMAN; HYPERCHOLESTEROLEMIA; JAUNDICE; LIPID ANALYSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MYOPATHY; PARALLEL DESIGN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO;

EID: 12744253815     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2004.13.1101     Document Type: Article

References (26)

1. Heart disease and stroke statistics - 2003 update. Dallas, TX: American Heart Association.
2. Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. JAMA 1998;279:1615.
3. Miettinen TA, Pyorala K, Olsson AC, et al. for the Scandinavian Simvastatin Survival Study Group. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Circulation 1997;96:4211.
4. Lewis SJ, Sacks FM, Mitchell JS, et al. for the CARE investigators. Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial. J Am Coll Cardiol 1998;32:140.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7.
6. Welty FR. Cardiovascular disease and dyslipidemia. in women. Arch Intern Med 2001;161:514.
7. Robinson D, LaRosa J, Wenger NK. Cardiovascular diseases. In: A report of the Task Force on the NIH Women's Health Research Agenda for the 21st Century. Agenda for Research on Women's Health for the 21st Century. Bethesda MD: NIH Publication No. 99-4386. 1999, vol 2.
8. Miller M, Byington R, Hunninghake D, Pitt B, Furberg CD. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Arch Intern Med 2000;160:343.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report on the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;19:2486.
10. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP). Arch Intern Med 2000;160:459.
11. Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341:498.
12. Bays HE, Dujovne CA. Drug interactions of lipid-altering drugs. Drug Safety 1998;19:355.
13. van Heek M, France C, Compton DS, et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997;283:157.
14. van Heek M, Farley C, Compton DS, Hoos L, Davis HR. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 2001;134:409.
15. Knopp RH, Gitter H, Truitt T, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 2003;24:729.
16. Davidson MH, McGarry T, Bettis R, et al. on behalf of the Ezetimibe Study Group. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002;40:2125.
17. Ballantyne CM, Houri J, Notarbartolo A, et al. Effects of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial. Circulation 2003;107:2409.
18. Kerzner B, Corbelli J, Sharp S, et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol 2003;91:418.
19. Melani L, Mills R, Hassman D, et al. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial. Eur Heart J 2003;24:717.
20. Sager P, Melani L, Lipka L, Strony J, Suresh R, Veltri E for the Ezetimibe Study Group. Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein. Am J Cardiol. 2003;92:1414.
21. Expert Panel on Detection, Evaluation, and Thatment of High Blood Cholesterol in Adults. Executive summary of the second report on the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015.
22. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
23. LaRosa JC. Outcomes of lipid-lowering treatment in postmenopausal women. Drugs Aging 2002;19:595.
24. Bass KM, Newschaffer CJ, Klag MJ, et al. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993;153:2209.
25. Mosca L, Grundy SM, Judelson D, et al. Guide to preventive cardiology for women. Circulation 1999;99: 2480.
26. Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the Healthy Women Study. Am J Cardiol 2002;90:71i.